Hi-Tech Pharmacal (HITK) Reports Sales of $58.5 million for the Fourth Quarter Ended April 30, 2013
7/9/2013 6:26:38 AM
Get the latest biotech news where you want it. Sign up for the free GenePool
Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) today reported results for the fourth quarter and year ended April 30, 2013.
•Net sales of $58.5 million for the fourth quarter compared to $61.3 million for the same prior year period
•GAAP loss of $4.6 million or $0.34 per diluted share for the fourth quarter
•Adjusted non-GAAP net income of $6.9 million or $0.50 per diluted share for the fourth quarter
Help employers find you! Check out all the jobs and post your resume.
comments powered by